SEC Form 4 · accession 0001076542-17-000078
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher R. Miller
Officer — Chief Financial Officer
Period of report
Jun 23, 2017
Accepted (ET)
Oct 3, 2017 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jun 23, 2017 | G | 800 | $0.00 | A | 252,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF2 | $1.00 | holding | — | — | — | — | — | COMMON STOCK | 306,000 | 306,000 | D |
Explanation of responses
- F1In January 2016, the Company granted to Mr. Miller 252,000 shares of restricted common stock of the Company, at par value of $0.001 (the "Shares"), for prior and then ongoing consulting services. As of the date of this filing, 228,000 Shares are vested and the remaining 24,000 Shares shall vest at the rate of 8,000 shares per month for a period of 3 months.
- F2On December 21, 2016, the Company granted to Mr. Miller 306,000 options to purchase shares of restricted common stock of the Company pursuant to the Company's 2016 Omnibus Incentive Plan (the "Option Shares"). The Option Shares vest at the rate of 8,500 shares per month for a period of 36 months. Each option shall expire 36 months from the date of vesting. As of the date of this filing, 85,000 options are vested.